ABOUT US
Our foundation is rooted in an unwavering commitment to making a meaningful global impact. We are driven by a desire to enhance lives and empower companies to develop and commercialize products that drive positive change. With extensive expertise in biotechnology, product and portfolio strategy, and government engagement, our team brings decades of collective experience to offer unmatched insights and solutions to our clients.
Passion for Global Public Health
Our substantial experience in the public health threat arena has cultivated a profound passion for global public health. This commitment fuels our dedication to addressing critical issues affecting communities worldwide.
Tackling Complex Challenges
We excel in addressing the most significant questions, requiring creative and pioneering solutions. Our focus extends to innovating solutions that balance sustainable, profitable businesses with serving the greater good.
Our Expertise
Our expertise spans the entire product lifecycle, from bench to bedside, including:
Our team’s experience and expertise enable us to illuminate the path forward for your organization, providing clarity and direction in an ever-evolving industry. We combine scientific expertise, product and portfolio management, and a deep understanding of the industry to help organizations navigate challenges and seize opportunities.
ASHLEY WOZNIAK
Ashley Wozniak is a dynamic leader with over 18 years of experience in the public health threat and medical countermeasure space. She has held key leadership roles at Cangene and Emergent BioSolutions, building a robust track record in strategic thinking and business acumen. Her career highlights include:
Strategic Vision and Leadership: Ashley’s unique blend of scientific and business expertise has led to her success in building high-impact teams and systems, driving cross-functional alignment, and managing complex reputational issues. She has also led 5-year strategic planning from the business unit level down to individual product roadmaps.
Global Business Leadership: As the General Manager and VP of Government Business at Emergent, Ashley managed a global team and a portfolio of 11 approved products across 30+ countries, resulting in significant revenue.
Late-stage R&D/Pre-launch/Launch Expertise: Ashley has led late-stage development and product launches for both commercial and medical countermeasure products across multiple therapeutic modalities and approval and distribution mechanisms.
Government and NGO Engagement: With a deep understanding of government strategy, funding, and contracting, Ashley has secured and delivered on eight contracts with the US government, totaling over $3 billion. She has also led teams to execute successful contracts for governments and NGOs in 30+ countries and integrate three key assets.
Governance and Change Management: Ashley’s experience includes establishing and leading high-performing teams through four significant reorganizations. Her passion for people and employee engagement are the foundation by which she approaches change management, and her skills include creating governance structures and establishing and fostering cross-functional alignment in matrixed environments.
Other Achievements: Ashley led the spin-off of Emergent’s biosciences division to Aptevo Therapeutics, established and led the Product Strategy team in the Therapeutics Business Unit, and served as Acting VP of Research and Development Therapeutics. She also played a pivotal role in COVID therapeutic development and commercial launches in partnership with BARDA and DoD.
Ashley holds a PhD in Molecular Biology from the University of Manitoba.